Previous research demonstrated that Hsp90α levels were higher in the serum of individuals with NAFLD, and there was a significant link between serum Hsp90 levels and steatohepatitis activity degree [101]. Here, HSP90AA1 is linked to metabolic dysfunction-associated steatotic liver disease.